Qin Tian

Title: Innovations of Qin Tian in Hepatic Targeted Drug Delivery Systems.

Introduction

Qin Tian is an accomplished inventor based in Tianjin, China. He has made significant contributions to the field of drug delivery systems, particularly focusing on liver-targeted therapies. His innovative work has the potential to improve treatment outcomes for liver cancer patients.

Latest Patents

Qin Tian holds a patent for a "Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof." This patent discloses a novel hepatic targeted drug delivery system and outlines a process for its preparation. Additionally, it presents a method for treating liver cancer, showcasing his commitment to advancing medical technology.

Career Highlights

Throughout his career, Qin Tian has been associated with notable institutions such as Nankai University and Tian Si Polymer Materials Technology Development Co. His work in these organizations has allowed him to develop and refine his innovative ideas in drug delivery systems.

Collaborations

Qin Tian has collaborated with esteemed colleagues, including Chuangnian Zhang and Tong Liu. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Qin Tian's contributions to hepatic targeted drug delivery systems represent a significant advancement in medical technology. His innovative approaches and collaborations have the potential to greatly impact the treatment of liver cancer.